Abstract: Cathepsin E is a major nonlysosomal, intracellular aspartic proteinase that localizes in various cellular compartments such as the plasma membrane, endosome-like organelles, and the endoplasmic reticulum (ER). To learn the segregation mechanisms of cathepsin E into its appropriate cellular destinations, the present studies were initiated to define the biosynthesis, processing, and intracellular localization as well as the site of proteolytic maturation of the enzyme in primary cultures of rat brain microglia. Immunohistochemical and immunoblot analyses revealed that cathepsin E was the most abundant in microglia among various brain cell types, where the enzyme existed predominantly as the mature enzyme. Immunoelectron microscopy studies showed the presence of the enzyme predominantly in the endosome-like vacuoles and partly in the vesicles located in the trans-Golgi area and the lumen of ER. In the primary cultured microglial cells labeled with [ 35S]methionine, >95% of labeled cathepsin E were represented by a 46-kDa polypeptide (reduced form) after a 30-mm pulse. Most of it was proteolytically processed via a 44-kDa intermediate to a 42-kDa mature form within 4 h of chase. This processing was completely inhibited by bafilomycin A 1, a specific inhibitor of vacuolar-type H + -ATPase. Brefeldin A, a blocker for the traffic of secretory proteins from the ER to the Golgi complex, also inhibited the processing of procathepsin E and enhanced its degradation. Procathepsin E, after pulse-labeling, showed complete susceptibility to endoglycosidase H, whereas the mature enzyme almost acquired resistance to endoglycosidases H as well as F. The present studies provide the first evidence that cathepsin E in microglia is first synthesized as the inactive precursor bearing high-mannose oligosaccharides and processed to the active mature enzyme with complextype oligosaccharides via the intermediate form and that the final proteolytic maturation step occurs in endosomelike acidic compartments.
tic proteinase of the pepsin superfamily, which is highly homologous to the lysosomal aspartic proteinase cathepsin D (EC 3.4.23.5) (Kageyama, 1995; Rawlings and Barrett, 1995; . Cathepsin E has the typical features common to other aspartic proteinases but has, in addition, several unique characteristics. For instance, the enzyme in mammalian cells is a two-chain glycoprotein consisting of two fully catalytically active monomers with an apparent molecular mass of 42 kDa, whereas other aspartic proteinases including cathepsin D are single-chain glycoproteins. Differing from cathepsin D, cathepsin E has a limited tissue distribution (Sakai et al., 1989) and localizes in various cellular compartments such as the plasma membrane, the endosome-like organelles, and the endoplasmic reticulum (ER) (Saku et al., 1991; Bennett et al., 1992; Yoshimine et al., 1992; Solcia et al., 1993) . However, the detailed function of cathepsin E in relation to its appropriate cellular localization is currently unknown.
The primary structure of procathepsin E has been determined from nucleotide sequence analyses of eDNA clones of human (Azuma et al., 1989) , guinea pig (Kageyama et al., 1992) , rabbit (Kageyama, 1993) , rat (Okamoto et al., 1995) , and mouse (Tatnell et al., 1997) and revealed that, structurally, the enzyme exhibits homology with other aspartic proteinases (Azuma et al., 1989; Kageyama et al., 1992; Okamoto et al., 1995) . The coding sequence of preprocathepsin E is composed of a signal peptide, a propeptide (activation segment), and the mature enzyme containing the two active-site aspartic acid residues and shows the presence of one (human and rabbit) or two (guinea pig and rat) or three oligosaccharide chains (mouse) in the single polypeptide. The potential N-glycosylation site in the amino-terminal portion is common to cathepsin E from all mammalian species examined, whereas that in the carboxy-terminal portion is missing in the enzyme from human and rabbit. Furthermore, the potential N-glycosylation site in the carboxy-terminal portion is also different between guinea pig and rat enzymes. The glycosylation of the enzyme may be involved in its targeting to its destinations, as shown in the case of lysosomal enzymes. Also, the nature of oligosaccharide chains of cathepsin E varies with different cell types or its cellular localization (Yonezawa et al., 1990; Takeda-Ezaki and Yamamoto, 1993; Tsukuba et al., 1993) , suggesting that the enzyme undergoes cell-specific carbohydrate modifications during biosynthesis. Thus, the processing events of cathepsin E are thought to include removal of the proregion at the amino-terminal end, the formation of the disulfide bond to generate the homodimer, and modification of the oligosaccharide chains.
In view of differences in the cellular localization and the carbohydrate structure and of the proposed extralysosomal roles of cathepsin E, the question of its biosynthesis, processing, mechanism of sorting, and delivery to different cellular compartments is especially important, to know its physiological significance. As cathepsin B exists predominantly as the mature form in rat and mouse brain (Nakanishi et al., 1994 (Nakanishi et al., , 1997 Amano et al., 1995) , we determined its distribution and cellular localization in the brain cells by using immunological procedures and chose the microglial cells as a predominant cell type expressing cathepsin E to clarify the biosynthesis, maturation, and intracellular localization of cathepsin E.
MATERIALS AND METHODS

Materials
L-[
35S]Methionine (>37 TBq/mmol) was purchased from Du Pont-New England Nuclear. Pansorbin (fixed Staphylococcus aureus) was from Cappel. Protein A-Sepharose and Percoll were from Pharmacia LKB Biotechnology. Endoglycosidases H (Endo H; S. griseus) and F (Endo F; Flavobacterium meningosepticum) were from Seikagaku Kogyo (Tokyo) and Boehringer Mannheim, respectively. Cell culture supplies were from GIBCO. Polyclonal antibodies against purified rat spleen cathepsin E (Yamamoto et al., 1978) and cathepsin D (Yamamoto et al., 1979) were raised in rabbits and purified by affinity chromatography as described previously (Yamamoto et al., 1985) . Polyclonal antibodies against the synthetic peptide Ser-Gln-Leu-SerGlu-Phe-Trp-Lys-Ser-His-Asn-Leu-Asp-Met, which corresponds to the prosequence comprising residues Ser23-Met36 of human procathepsin E, were raised in rabbits and purified on the peptide-Sepharose affinity column. The purified antibodies cross-reacted with procathepsin E only. Antibodies recognizing microglia (0X42) and glial fibrillary acidic protein (GFAP) were purchased from Serotec and Dako, respectively. Brefeldin A was from Sigma Chemicals. Bafilomycin A 1 was provided by Dr. K. Oda (Niigata University, Niigata, Japan). Papain was from Worthington (Freehold, NJ, U.S.A.). All other chemicals were of reagent grade from various commercial sources.
Forebrain ischemia
Transient forebrain ischemia was induced in male Wistar rats (150-200 g) by clamping the carotid arteries bilaterally as described previously . In brief, animals were anesthetized with sodium pentobarbital (40 mg/kg i.p.) and bilateral vertebral arteries were electrocauterized at the level of the first vertebra. On the following day, the common carotid arteries were gently exposed under light ether anesthesia and both arteries were occluded with a vascular clamp for 15 mm. Rats showing the loss of righting reflex during the period of ischemia were used as an ischemic group.
Cell culture
Microglia were isolated from mixed primary cell cultures of the cerebral cortex from 3-day-old male Wistar rats according to the method described by Nakajima et al. (1992) . The cerebral cortex was dissected, meninges and blood vessels removed, soaked in Ca 2~-and Mg2~-free phosphatebuffered saline (CMF-PBS) (GIBCO, Gaithersburg, MD, U.S.A.), and minced with a razor blade. Then the tissue was enzymatically dissociated by incubation twice for 15 mm at 37°C in CMF-PBS containing papain (90 U/ml), DNase (Worthington; 2,000 U/ml), D,L-cysteine-HCI (2.23 mgI ml), bovine serum albumin (2 mg/ml), and glucose (50 mg/ml). After termination of the reaction by adding fetal calf serum (FCS), the tissue fragments were isolated by centrifugation and resuspended in the culture medium consisting of Dulbecco's modified Eagle's medium (DMEM), 0.3% NaHCO 3, 50 U/mI penicillin, 100~sg/ml streptomycin, and 10% FCS. The tissue fragments were then dissociated by gentle passage through plastic tips with three different diameters. The mechanically dissociated cells were filtered through a cell strainer with a 70-~.tmpore size (Falcon, Franklin Lakes, NJ, U.S.A.). The dissociated cells were seeded into plastic flasks at a density of l0~/300cm 2 and maintained at 37°Cin a 10% C0 2/90% air atmosphere. Subsequent medium replacement was performed every 3 days. After 10-14 days in culture, floating cells and weakly attached cells on the mixed primary cultured cell layer were isolated by gentle shaking of the flask for 3-5 mm. The resulting cell suspension was transferred to plastic dishes and allowed to adhere at 37°C.Unattached cells were removed after 30 mm; microglia were isolated as strongly adhering cells. About 90% of these attached cells were positive for OX42 or OX6, markers for macrophage/microglial cell types. Astrocytes were also prepared from the mixed primary cell culture. After isolation of microglia from the mixed cell culture, oligodendrocytes were removed by vigorously shaking with a shaker (BR-4OLF, TAITEC, Japan) with 160-200 strokes/mm for 16 h at 37°C. Tightly adhering cells were recovered by trypsin treatment and seeded into plastic flasks at a density of 5 x l0~/75cm 2 and maintained at 37°C in a 10% CO 2/90% air atmosphere. Subsequent medium replacement was performed every 2 days. After 10 days in culture, confluent cells were used as astrocytes in experiments. About 95% of these cells were positive for anti-GFAP antibody, a marker for astrocytes.
Homogeneous populations of rat peritoneal macrophages were obtained from 10-12-week-old male Wistar rats injected peritoneally with 6% casein sodium (Nutrose) (20 ml/rat) 3 days before harvesting cells. Nutrose-elicited macrophages were isolated by peritoneal lavage with RPMI-1640 medium followed by adherence to 100-mm plastic Petri dishes in the presence of 10% FCS in RPMI-1640. Adherent macrophages were washed vigorously with PBS and scraped off the dishes with a rubber policeman in the medium. Primary cultures were used for experiments immediately after their isolation.
Immunocytochemistry
For indirect immunofluorescent microscopy, isolated microglia were transferred to the chamber slides (Nunc, Naperville, IL, U.S.A.). Unattached cells were removed after 30 mm and strongly attached microglia were fixed by 4% paraformaldehyde for 30 mm at room temperature. After washing with PBS, the cells were incubated with normal goat serum for 4 h at room temperature and then with specific antibodies for cathepsin E and cathepsin D for 1 h at 37°C.After washing, the cells were incubated with 0.5% biotinylated goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA, U.S.A.) for 2 h at room temperature under gentle agitation.
After washing, the cells were incubated with 0.5% streptavidin-conjugated fluorescein isothiocyanate (Amersham) for 2 h at room temperature. After several washes with PBS, the cells were coverslipped with a mixture of glycerin and PBS (1:1) and examined using a fluorescence microscope (Leitz DMR, Leica). Controls were incubated with nonimmune rabbit IgG instead of specific IgG. The detailed procedures for double-staining immunochemistry have been described previously (Nakanishi et al., , 1994 (Nakanishi et al., , 1997 . In brief, parasagittal cryosections (40 /im) of the neostriatum were immunostained by anti-cathepsin E and anti-cathepsin D IgG at a dilution of 1:800-2,400 in PBS with the avidin-biotinperoxidase complex method (Vectastain kit, Vector). The immunoreactivity for each enzyme was detected using 3 ',3-diaminobenzidine (DAB) with nickel ammonium sulfate intensification, which yielded a dark blue color. The sections immunostained for these enzymes were further stained with anti-GFAP antibody or 0X42 according to the peroxidaseantiperoxidase method (Zymed Laboratories, South San Francisco, CA, U.S.A.), and DAB without nickel ammonium sulfate was used as a chromogen yielding a brown color.
Immunocytochemical analysis using electron microscopy was performed with cryothin-section immunogold labeling, originally designed by Tokuyasu (1980) . Microglia plated on the dishes were fixed first with 0.1% glutaraldehyde and 4% paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4) for 10 mm at room temperature, then with 4% paraformaldehyde alone in the same buffer for 30 mm. The fixed cells were washed with the buffer, scraped, and centrifuged at 250 g for 5 mm. Pelleted cells were suspended with 10% gelatin in 0.1 M phosphate buffer and again centrifuged at 1,200 g for 5 mm. Gelatin-embedded cells were immersed in 2.3 M sucrose in the buffer and frozen in liquid nitrogen. Frozen samples were used for cryothin-section gold labeling. Cryothin sections were cut with an ultramicrotome (Reichert-Nissel Ultracut S, Nissei Sangyo, Japan). Sections on grids were treated with 1% bovine serum albumin in PBS, incubated with anti-cathepsin E IgG overnight and then with anti-rabbit IgG coupled to 5-nm colloidal gold particles (Amersham) for 1 h. Control sections were incubated with the mixture of anti-cathepsin E IgG and the purified enzyme. The grids were then dehydrated, embedded in LR white, and examined by JEOL JEM-100CX or Hitachi H-7100 electron microscope.
Electrophoresis and immunoblotting
Proteins were separated on 5-12% polyacrylamide gels under reducing conditions according to the method of Laemmli (1970) and subsequently blotted onto nitrocellulose membranes and immunostained as described previously (Amano et al., 1995; Nakanishi et al., 1997) .
Pulse-chase experiments
Primary cultures of rat microglia (l0~-l0~cells per dish) were preincubated at 37°Cfor 90 mm in methionine-free DMEM containing 10% FCS. The cells were pulse-labeled for 30 mm with [ 35S]methionine (1 mCi/2 ml per dish) and chased in fresh DMEM containing the excess of unlabeled methionine and 10% FCS. Cells were preincubated at 37°C for 90 mm with bafilomycin A 1 (5 x i0~M) or brefeldin A (5 j.tg/ml). Either agent was present in the medium throughout the pulse-chase periods. At each time interval, the cells were isolated by centrifugation and resuspended in 10 mMTris-HC1 buffer (pH 7.5) containing 150mM NaCl, 5 mM EDTA, 1% Triton X-lOO, 0.5% sodium deoxycholate, 0.02% sodium azide, and a protease inhibitor cocktail [leupeptin, chymostatin, antipain, pepstatin A, and phenylmethylsulfonyl fluoride (PMSF); 10 ,ug of each inhibitor/mi]. After sonication at 0°Cfor 3-5 mm, the cell extracts were isolated by centrifugation. Both cell extracts and media were rapidly frozen in liquid N2 and stored at -75°Cuntil use.
Conditions for labeling of macrophages (1o~cells per dish) with [ 35S]methionine were essentially the same as described above. The cells were preincubated at 37°C for 1 h in methionine-free RPMI-1640 and pulse-labeled with [35S]methionine for 30 mm and then chased in complete RPMI-1640 at 37°C. At the indicated times of chase, these cells were separated from the medium, washed with PBS, and lysed in 10 mM Tris-HC1 buffer (pH 7.5) containing 150 mM NaC1, 2 mM EDTA, 1% sodium dodecyl sulfate (SDS), 0.5% Triton X-l00, and the protease inhibitor cocktail.
Immunoprecipitation
Both cell lysates and media were thawed and ultrasonicated, and then centrifuged at 105,000 g for I h. The resultant lysates and media were preincubated with 50~.tl of Pansorbin (Calbiochem) (30% cell suspension) at 4°Cfor 1 h to minimize nonspecific binding of protein A beads. After centrifugation at 6,500 g for 20 mm, radiolabeled cathepsin E and cathepsin D in the precleared lysates and media were immunoreacted by incubation first with discriminative antibodies specific for each mature enzyme at 37°Cfor 10 mm and then at 4°Cfor 16 h. Immune complexes were isolated by mixing at 4°Cfor 3 h with 50~i1of an 80% suspension of protein A-Sepharose beads in PBS with gentle agitation. The sedimented beads were washed three times with 10 mM Tris-HCI (pH 7.5) containing 0.1% SDS, 0.1% Triton X-100, 2 mM EDTA (buffer A), three times with buffer A containing 1 M NaCl and 0.1% sodium lauryl sarcosinate, and twice with PBS. The beads were boiled for 3 mm at FIG. 1. lmmunohistochemical staining of microglia (A) and astrocytes (B) isolated from the cerebral cortex from 3-day-old rats. Microglia and astrocytes were stained by 0X6 and anti-GFAP antibody, respectively. Bars = 20~zm.
100°Cwith 50~.tl of 2% SDS/0.5 mM EDTA/5% sucrose/ 5 mM Tris-HC1 (pH 8.0) (solubilizing buffer) with 0.5% 2-mercaptoethanol. The supernatant was analyzed by SDSpolyacrylamide gel electrophoresis (PAGE) (Laemmli, 1970) . Radioactive bands were detected by fluorography, using Amplify (Amersham) on Konica medical x-ray film. Apparent molecular weights were determined by using ' 4C-methylated standards (Amersham).
Endo H and Endo F digestion
Radiolabeled immunoprecipitates were dissolved by being boiled for 3 mm in 10~sl of 1% SDS in water. To this was added 90~l of 50 mM sodium citrate buffer (pH 6.0) containing a mixture of protease inhibitors (chymostatin, leupeptin, and pepstatin, each at 30 ,ug/ml and 1 mMPMSF) and 15 mU of Endo H or 100 mU Endo F. After incubation for 18 h at 37°C,the samples were analyzed by SDS-PAGE followed by fluorography.
Determinations
Acid proteinase activity was determined at pH 3.8, using acid-denatured hemoglobin as a substrate as described previously .
RESULTS
Identification and intracellular localization of cathepsin B in rat microglial cells
Morphologically, most of the isolated microglial cells had ameboid and rod-shaped cell bodies with no or few thick processes. As these cells were positively stained for 0X6 directed against major histocompatibility complex (MHC) class II molecules (Fig. 1A) and exhibited phagocytic activity (data not shown), the cellular phenotype of the isolated microglia was found to resemble activated microglia at sites of pathology. In contrast, the cellular phenotype of isolated astrocytes is considered to be protoplasmic type, because most showed polygonal and well-spread morphology with no or few thick processes (Fig. 1 B) .
To identify cathepsin E from cultivated glial cells, indirect immunofluorescence staining and immunoblot analyses were performed in the final preparations of microglia and astrocytes isolated from the cerebral cortex of 3-day-old rats, using affinity-purified polyclonal antibodies specific for cathepsin E. As shown in Fig.  2A , the microglial cells displayed punctate fluorescence over the whole cytoplasm. This pattern appeared to be characteristic of vesicular protein expression. In addition, the microglial cells showed the perinuclear, reticulate fluorescent staining characteristic of proteins retained in the ER. In contrast, astrocytes showed little immunofluorescence for cathepsin B (Fig. 2C) . Both microglia and astrocytes showed the intense punctate staining with monospecific antibodies for cathepsin D (Fig. 2B and D) . No immunoreaction was detected in control experiments with nonimmune IgG.
The total aspartic proteinase activity (cathepsin E plus cathepsin D) was measured in cell extracts of both microglia and astrocytes. The mean specific activity from microglia (21.1 ± 1.9 U/mg of protein, n = 6) was significantly higher than that from astrocytes (9.6 ±0.9 U/mg of protein, n = 5) (p <0.01; Student's t test, two-tailed). As the cellular distribution of cathepsin D in these two glial cell types appeared to be similar, the higher aspartic proteinase activity in microglia, compared with astrocytes, is likely to be due to the presence of cathepsin E in these cells. The microglial distribution of cathepsin E was further confirmed by SDS-PAGE under reducing conditions and immunoblotting. Microglial cell extracts produced an intense protein band with an apparent molecular mass of 42 kDa, whereas the astrocyte extracts showed a faint band with the same molecular mass (Fig. 3A) . When the microglial extracts were treated with monospecific antibodies for procathepsin E, no immunoreactive protein band was detectable (Fig. 4B) . Under the
FIG. 2.
Immunofluorescence microscopy of microglia (A and B) and astrocytes (C and D) isolated from the cerebral cortex from 3-day-old rats. Both glial cells were fixed and stained with affinity-purified polyclonal antibodies specific for cathepsin E (A and C) and cathepsin 0 (B and D). Punctate and reticular stainings of cathepsin E were seen in microglia but not in astrocytes. Granular staining of cathepsin 0 was observed in both microglia and astrocytes. Bar = 10 jsm.
same conditions, the tissue extracts of rat spleen, in which cathepsin E exists predominantly as the proenzyme (Okamoto et al., 1995) , showed a single protein band with an apparent molecular mass of 46 kDa with anti-procathepsin B IgG, as well as anti-mature cathepsin E IgG ( Fig. 4A and B) . On SDS-PAGE under nonreducing conditions, the 46-and 42-kDa species were detected at the positions of 90 and 82 kDa, respectively (data not shown). These results indicate that
FIG. 3.
Immunoblot analyses of the cell extractsof microglia and astrocytes from rat cerebral cortex by affinity-purified antibodies specific for cathepsin E (A) and cathepsin 0 (B). The cell extracts from the respective glial cells were analyzed by SDS-PAGF under reducing conditions followed by immunoblotting. CE, Cathepsin E; CD, cathepsin 0; Mic, microglia; Ast, astrocytes. The amounts of protein applied in the left and right lanes of each glial cell were 30 and 70 /ig, respectively. the newly synthesized procathepsin E in the microglia forms the dimeric form via a disulfide bond at an early stage of biosynthesis and then undergoes complete proteolytic processing to generate the mature form. In contrast, cathepsin D was shown to exist in both microglia and astrocytes as a 42-kDa enzyme corresponding to the mature form after SDS-PAGE under both reducing (Fig. 3B ) and nonreducing conditions (data not shown), suggesting that the proteolytic processing   FIG. 4. Immunoblot analyses of the cell extracts of microglia and spleen from the rat by affinity-purified antibodies specific for mature cathepsin E (A) and procathepsin F (B). Both cell extracts (70~tgeach) were analyzed by SDS-PAGE under reducing conditions followed by immunoblotting. Microglia, exclusively, contain the mature cathepsin E, whereas spleen extracts showed the predominant presence of procathepsin F. CE, cathepsin E; proCE, procathepsin E; Mic, microglia; SpI, spleen.
FIG. 5. A-D:
Immunoelectron microscopic localization of cathepsin E in rat microglia. Gold particles indicating the antigenicity of cathepsin E were predominantly associated with endosome-like organelles (arrowheads in A). Small amounts of gold particles were also found in the Golgi-related vesicles (small arrows in A, B, and C) and in the lumen of the ER (large arrows in C and D). No gold particles were observed in lysosome-like organelles (surrounded by arrowheads in 0). E, endosome-like structures; G, Golgi complex; N, nucleus; L, lysosomelike organelle. Bar = 0.5 pm.
events to generate mature cathepsin D also occur in these cells.
The intracellular localization of cathepsin E in the microglia was further examined at the electron microscopic level by immunolabeling ultrathin sections. Labeling for cathepsin E was predominantly associated with endosome-like vacuoles (Fig. 5A) , and significant labeling was also observed in vesicles proximal to the trans-Golgi area ( Fig. 5B and C) . In addition, appreciable labeling was detected in the lumen of the ER (Fig. SC) . However, no labeling was observed on mitochondria, lysosome-like dense granules (Fig. 5D) , or within nuclei. No immunoreaction was detected in control sections with nonimmune IgG.
The in vivo alteration in the cellular level of cathepsin E, as well as cathepsin D, was examined in resting and activated microglia. For this, transient forebrain ischemia was induced in rats. Under the conditions used, selective neuronal degeneration was observed in the hippocampal CAl subfield and the neostriatal dorsolateral portion after forebrain ischemia, as described previously . Activated microgha, as well as reactive astrocytes, accumulated extensively in these regions of selective neuronal vulnerability from postischemic rats. Figure 6 illustrates doubleimmunostaining patterns in the dorsolateral portion of neostriatum from control and postischemic rats with 0X42, a marker for microglia, and antibodies specific for cathepsins E and D. Control neostriatal sections from untreated rats showed the presence of weakly stained 0X42-positive microglia having fine ramified processes, suggesting quiescent microglia. These 0X42-positive microglial cells were occasionally and slightly stained with antibodies to cathepsin E (Fig.   6A ). In the postischemic neostriatum, proliferation of hypertrophic 0X42-positive microglial cells having i. Neurochem., Vol. 70, No. 5, 1998 
FIG. 6. Double-staining immunohistochemistry showing the localization of cathepsin F (A and C) and cathepsin 0 (B and D) in the identified microglial cells in rat neostriatal dorsolateral portion from control rats (A and B) and the postischemic rats 7 days after transient forebrain ischemia (C and 0). 0X42-positive and cathepsin E-or cathepsin D-positive cells were demonstrated by brown
and blue-black colors, respectively. In control sections (A and B), 0X42-positive microglial cells (brown) having fine ramified processes, representative ofquiescent microglia, were occasionally and slightly stained with antibodies to cathepsin F (A, arrows). In the postischemic neostriatum, proliferation of hypertrophic 0X42-positive microglial cells having short and thick processes, representative of activated microglia, were observed, and the immunoreactivity for cathepsin F was increased in these activated microglial cells (C, arrowheads). The immunoreactivity for cathepsin 0 observed in quiescent microglia (B, arrows) was also increased in the activated microglia (0, arrowheads). The arrow in 0 indicates a striatal neuron. Bar = 60 pm.
short and thick processes, representative of activated microglia, were observed in the neostriatal dorsolateral portion and the immunoreactivity for cathepsin B was markedly increased in these activated microglial cells (Fig. 6C) . The immunoreactivity for cathepsin D was found in ramified microglia as coarse intraplasmic granules (Fig. 6B ) and also increased after cellular activation of microglia (Fig. 6D) . Thus, it is more likely that increased levels of cathepsin E and cathepsin D reflect the enhanced endosomal/lysosomal proteolytic system in activated microghia in response to postischemic neuronal degeneration.
Biosynthesis and processing of cathepsin E
To follow the biosynthesis and processing of cathepsin E, the primary cultures of microglial cells were labeled with [ 35Slmethionine for 30 mm and then chased for up to 6 h. Labeled polypeptides present in the cells and secreted in the medium were immunoprecipitated and analyzed by SDS-PAGE under reducing conditions followed by fluorography. After the 30-mm pulse, cathepsin E was observed mainly as a polypeptide with an apparent molecular mass of 46 kDa (Fig.  7A) , which corresponded well with that of procathepsin E isolated from human erythrocytes (Takeda-Ezaki and and Chinese hamster ovary (CHO) cells transfected with human cathepsin E eDNA . After a chase of 2 h, most of the polypeptide was converted to a 44-kDa polypeptide corresponding to the intermediate form isolated from the above CHO cells . The 44-kDa polypeptide was processed further to a 42-kDa polypeptide within the next 4 h, after which it leveled off. Because the 46-, 44-, and 42-kDa polypeptides were detected at positions of 90, 84, and 82 kDa after SDS-PAGE under nonreducing conditions (data not shown), respectively, all the forms of cathepsin E were dimerized at the early stages of biosynthesis. The 46-kDa polypeptide after pulse-labeling was rapidly converted to the 42-kDa form by a brief acid treatment at pH 3.5 and 37°Cfor 10 mm, whereas the 42-kDa form obtained after 6-h chase showed no alteration in the migration rate (i.e., size) under the same conditions (Fig. 8) . The rapid conversion of the 46-kDa polypeptide into the 42-kDa form by the brief acid treatment was inhibited by inclusion of pepstatin (50 ,ag/ml) (data not shown), suggesting its autocatalytic activation. In addition, antibodies specific for procathepsin B reacted with the 46-kDa form only, but not with the 42-kDa form (data not shown). These results indicate that the initially synthesized procathepsin E, with a molecular mass of 46 kDa, undergoes complete proteolytic processing, yielding the mature form of 42 kDa via the 44-kDa intermediate form.
In the medium, it is noteworthy that a small amount (<10%) of the precursor form of cathepsin E was secreted as a 48-kDa polypeptide and accumulated in the medium during a 2-h chase period, and then considerably degraded within the next 4 h. Because microglia reside as brain macrophage precursors and can be activated to be the phagocytic macrophage-like cells in response to brain injuries (Streit and Kreutzberg, 1988) , microglia and macrophages are thought to share a variety of functional roles, suggesting their common involvement in the immune response, wound healing, and disposal of cell debris. Thus, the biosynthesis and processing of cathepsin E in rat peritoneal macrophages were also examined by pulse-chase experiments under the same conditions as above (Fig. 7B) . The processing events of the enzyme in macrophages proceeded in a similar manner as those in microglia. Figure 7D illustrates the effect of the fungal metabolite brefeldin A on the proteolytic processing of cathepsin E. This agent has been shown to inhibit export of newly synthesized proteins at an early step in protein transport (Fujiwara et al., 1988) and to also cause a reversible redistribution of Golgi resident proteins into the ER (Doms et al., 1989) . Thus, the intracellular organelles that belong to the exocytic and endocytic pathways, including the Golgi complex, secretory vesicles, endosomes, lysosomes, and the plasma membrane, are thought to be affected by brefeldin A. Under the conditions used, the processing events of cathepsin E were completely blocked by this agent and the enzyme remained in the 46-kDa precursor form, suggesting that the enzyme accumulates in the ER and/or in an early Golgi compartment. Therefore, the conversion from procathepsin B into the intermediate form as well as the mature form occurs in the post-Golgi compartment. In addition, brefeldin A completely prevented secretion of the enzyme in the medium, suggesting that this agent also inhibits the transport of subspecies of the precursor, which are thought to be secreted to the medium by an alternative secretory pathway, at the exit from the ER.
The internal acidification of some compartments in the vacuolar system has been shown to be important in biosynthesis, processing, sorting, transport, and degradation of proteins and other macromolecules (Mellman et al., 1986) . In vivo, the specific inhibitor of vacuolar-type H + -ATPase bafilomycmn A 1 can effec -FIG. 9 . Susceptibility of cathepsin F in the primary cultured microglia to Fndo H. The primary cultured microglia were pulselabeled with [ 35S] methionine for 30 mm and chased for the times indicated. At indicated times, the cell lysates (C) and the medium (M) were prepared and used for immunoprecipitation of cathepsin F. The immunoprecipitates were solubilized with SOS and incubated in the presence or absence of Fndo H. Then they were analyzed by SOS-PAGE under reduced conditions and fluorography.
tively inhibit acidification of endosomes, lysosomes, and phagosomes, resulting in the inhibition of lysosomal protein degradation and targeting of lysosomal acid hydrolases and cholesterol to the lysosome, without perturbation of the formation of intracellular organelles like Golgi vesicles and endosomes and alteration of the morphology of vacuolar compartments. Bafilomycin A 1 is also found to inhibit acidification of the trans-Golgi network, resulting in the irihibition of prohormone processing (Xu and Shields, 1994) . Thus, we analyzed the effect of this agent on the processing of procathepsin E (Fig. 7C) . Bafilomycin A1 showed a pronounced inhibitory effect on the intracellular processing of procathepsin E to the mature form, and therefore, no mature enzyme was detected in the bafilomycin A1-treated cells even after a 6-h chase period. Concomitantly, a large amount of the precursor was found to be released into the medium. The increased secretion of procathepsin E attained the maximal value at =~4-hchase and remained constant during the next 2-h chase. Together with the immunocytochemical data (Fig. 5) , these findings indicate that the proteolytic maturation of procathepsin E mainly occurs in endosome-like acidic organelles. The results also support that low pH plays a critical role in the endosomal trafficking and autocatalytic activation of cathepsin E.
Characterization of N-linked oligosaccharide chains of cathepsin E
Cathepsin B is known to be N-glycosylated with either high-mannose or complex-type oligosaccharide chains. The type of glycosylation appears to be dependent on the cell type or its cellular localization. Thus, to determine if the enzyme in microglia acquires complex-type oligosaccharide chains, the immunoprecipitates from the metabolically labeled microglia after a chase of 0 or 6 h were treated with Endo H, as well as Endo F, and then subjected to SDS-PAGE followed by fluorography. As shown in Fig. 9 , the 46-kDa proenzyme (30-mm pulse) was completely sensitive to Endo H, migrating faster in electrophoretic mobility than the untreated protein. Endo H treatment of the propeptide reduced its apparent molecular mass, which was equivalent to a loss of '~4kDa. Rat cathepsin E is known to have two possible N-glycosylation sites (at positions Asn 73 and Asn305 of procathepsin E) within a single polypeptide (Okamoto et al., 1995) . The observed difference in its molecular mass was consistent with the size of two high-mannose oligosaccharide chains. In contrast, the 42-kDa mature enzyme (6-h chase) acquired resistance to Endo H. Only a small amount of the 42-kDa enzyme showed sensitivity to Endo H. The precursor of 48 kDa in the medium (6-h chase) was mostly resistant and remained, in part, sensitive to Endo H. Similar results were obtained with Endo F (data not shown). These results suggest that the intracellular precursor contains exclusively the high-mannose type of oligosaccharides, whereas the intracellular mature enzyme and the precursor from the medium have acquired the largely complex type of sugar chains.
DISCUSSION
This study is the first report on the biosynthesis and processing of cathepsin B in cells naturally expressing this enzyme. In microglia, cathepsin E resides intracellularly and only a small amount of the protein is excreted in the culture medium. On metabolic labeling with [35Sjmethionine for 30 mm, the 46-kDa precursor form was first identified. During a 6-h chase, it was processed via the 44-kDa intermediate to the 42-kDa mature enzyme. Generation of the intermediate form was completely inhibited by bafilomycin 1 (Fig. 6C) , as well as brefeldin A (Fig. 7D) . The 46-kDa proenzyme was converted rapidly to the 42-kDa mature enzyme without generation of the 44-kDa intermediate by brief acid treatment (Fig. 8) . We have previously shown that the activation of procathepsin E purified from rat spleen proceeds most rapidly at pH 3.0-4.0 and 37°C,and the intermediate form was scarcely detected under the conditions used (Okamoto et al., 1995) . In contrast, Kageyama et al. (1992) also reported that the intermediate form was generated at a very low level only when procathepsin E (from guinea pig) was treated under more gentle conditions (at pH 2.0 and 14°Cfor~15 mm). Therefore, the difficulty in generating the intermediate form in vitro even at weakly acidic pH suggests that the proteolytic processing of procathepsin E to the intermediate occurs before being transported to the acidic trans-Golgi. Knowing the amino-terminal sequences of the 42-kDa mature enzyme from rat spleen (Okamoto et al., 1995) and the 44-kDa intermediate from CHO cells expressing human cathepsin E , we presume that the 44-kDa intermediate is 10 residues longer at the amino-terminal end than the mature enzyme. Of course, the exact site of cleavage generating the intermediate in microglia remains to be determined. Further proteolytic processing resulting in the mature enzyme is likely to occur proximal to the trans-Golgi region, probably in the trans-Golgi network or endosome-like acidic compartments. Supportive evidence for this was obtained by the immunocytochemical localization of cathepsin E with monospecific antibodies for the mature enzyme. With the antibodies, we obtained the predominant labeling of endosome-like vacuoles. A small labeling of the vesicles near the Golgi region and the lumen of the ER with the antibodies may represent the enzyme precursors that are en route to the endosome-like vacuohes.
To determine whether a low pH sorting step is required to route cathepsin E to its final destination, the effect of pH-altering drug bafilomycin A 1, on the biosynthesis and secretion of the enzyme in microglial cells, was examined. In the bafilomycmn A1-treated cells, proteolytic processing of the proenzyme was completely prevented and the enhanced secretion of the proenzyme was observed. The prevention of processing for cathepsin B could be due to an increase of pH in intracellular acidic compartments including endosomes. Therefore, it appears likely that the final proteolytic processing step of cathepsin E occurs in the endosome-like organelles or the trans-Golgi network. Until the moment that the secretory and lysosomal pathways are diverted from the cathepsin E-sorting pathway in the trans-Golgi region, no final proteolytic maturation of the proenzyme appears to have occurred. Further, procathepsin E, like procathepsin D, has been shown to be catalytically inactive and to be autocatalytically activated in~acidic environments (Kageyama et al., 1992; Takeda-Ezaki and Yamamoto, 1993; Okamoto et al., 1995) . The physiological function of the enzyme activation at a late stage of biosynthesis is incompletely understood, but it may serve to prevent the deleterious action of the enzyme in preendosomal compartment. The acidic environment for the last proteolytic maturation step appeared to be necessary to acquire an enzyme configuration not only for autocatalytic activation but also for maintaining the optimal activity toward substrate proteins.
Rat cathepsin B has two possible N-glycosylation sites at the Asn 73 and Asn305 residues of procathepsin E (Okamoto et al., 1995) . Previously, Asn73 was identified as one of the two putative oligosaccharide attachment sites, but Asn305 was not assigned. However, Endo H treatment of the procathepsin E reduced its apparent molecular mass, which was equivalent to a loss of -~4kDa. This prompted us to reexamine the possible N-glycosylation sites of the enzyme, and therefore Asn305 was identified as another oligosaccharide attachment site. The intracellular cathepsin B precursor generated in a 30-mm labeling period was equally sensitive to Endo H as to Endo F and had exclusively, therefore, the high-mannose type of oligosaccharide chains. However, at least one of the two oligosaccharide chains was apparently rebuilt to the complex type of structure during a 6-h chase period. Because the apparent molecular mass of the precursor was not changed when exit from the ER was prevented by brefeldin A and when intracellular acidification was prevented by bafilomycin A 1, the complex glycosylation of cathepsin E appeared to occur in the transGolgi. Furthermore, when glycosylation was completely blocked by tunicamycin, the unglycosylated precursor did not exit from the ER and was rapidly degraded without secretion into the extracellular medium (T. Tsukuba, S. Ikeda, H. Sakai, D. F. Sastradipura, H. Nakanishi, and K. Yamamoto, manuscript submitted'). Therefore, it is more likely that the oligosaccharide chains are of importance for the intracellular transport and stability of procathepsin B, although the role of each N-glycosylation site in these events remains to be resolved. In contrast, most of the lysosomal cathepsin D, as well as procathepsin D, is known to remain susceptible to digestion by Endo H throughout the life of the enzyme (von Figura and Hasilik, 1986; Komfeld and Mellman, 1989) . In addition, in the course of intracellular transport from the ER via the Golgi complex to the lysosome, cathepsin D acquires phosphomannosyl residues that enable it to bind mannose-6-phosphate receptors (MPRs) on the biosynthetic pathway (von Figura and Hasilik, 1986; Kornfeld and Mellman, 1989) . After binding to the receptors, they are targeted to the lysosome, although the MPR-independent, alternative segregation mechanisms have also been known to exist in various vertebrate tissues (Owada and Neufeld, 1982; Rijnboutt et al., 1991a,b; Capony et al., 1994) . However, there is no evidence thus far, indicating phosphorylation of the oligosaccharide chains of cathepsin E or of its polypeptide chains. Also, when microghia were labeled with [ 32P]phosphate (2 mCi/dish) for 6 h in this study, the 32P radioactivity was barely detectable in the immunoprecipitated cathepsin B (unpublished observation), thereby indicating that procathepsin E is sorted for targeting to the endosome-like organelles without a recognition marker for MPR. These discrepancies between cathepsin B and cathepsin D may serve to sort each other and to target their distinct destinations.
The precise function of cathepsin E in microglia, as well as in macrophages, is currently unknown. However, because cathepsin B is considered to be synthesized as a catalytically inactive precursor protein and completely processed to the catalytically active mature enzyme in the endosome-like vacuoles of these cells, the enzyme is likely to play a crucial role in the endosomal proteolytic system. Differential localization between cathepsmn B and cathepsin D in microglia is consistent with previous data showing their different cellular localization in various cell types, such as rat kidney cells, human gastric cells (Saku et al., 1991) , and rat neutrophils (Ichimaru et al., 1990) . However, a significant amount of cathepsin D has also been shown to localize in endosomes, besides lysosomes, in rabbit macrophages (Diment et al., 1988 ) and human hepatoma cell line HepG2 cells (Rijnboutt et al., 1991b) . In these cells, procathepsin D is membrane associated in the endosomes and its membrane association disappeared concomitantly with proteolytic processing of the proenzyme. Therefore, cathepsin E may share some common function with cathepsin D in extralysosomal proteolysis in the same compartment of a few cell types, although neither colocalization nor membrane association of cathepsin E and cathepsin D in endosome-like organelles is evident in rat microglia. More recently, we have shown that cathepsin E in brainstem neurons of the aged rat colocalizes with cathepsin D in the lipofuscmn-containing lysosomes (Nakanishi et al., 1997) , suggesting that certain cellular stimuli can induce the alteration in the intracellular localization of cathepsin B to lysosomes, which could be related to the enhanced endosomal/lysosomal proteolytic system and/or altered intracellular protein catabolism. Therefore, a pronounced elevation of the cellular cathepsin B level in activated microglia appears to explain the enhanced endosomal/lysosomal proteolytic system. Because microglia are known to be activated to phagocytic macrophage-like cells in response to brain injuries (Streit and Kreutzberg, 1988) , cathepsin B accumulated in these cells may be involved in the process of digestion of the damaged neurons through the endosomal/ lysosomal proteolytic system. Microglia are also proposed as the mediators of immune response in the brain, because the activated microglia express MHC class II antigens and thus present antigens to T lymphocytes and secrete cytokines (Giuhan and Baker, 1986; Frei et al., 1987 Frei et al., , 1989 . A high concentration of cathepsin E was also contained in peritoneal macrophages, where the proteolytic processing of procathepsin B was as efficient as that in microglia. Recently, it has also been shown that cathepsmn E is closely linked with the proteolytic processing of exogenous antigens (Bennett et al., 1992) and the invariant chain (Marie et al., 1994; Kageyama et al., 1996) through the endosomal/lysosomal system of antigen-presenting cells. Therefore, the enzyme accumulated in microglia as the mature enzyme may play a role in the immune response in brain tissues. Finally, it is noteworthy that cathepsin E has been detected by immunohistochemistry in microglia accumulated around the core of senile plaques in Alzheimer's disease brain (Bernstein and Wiederanders, 1994) , because amyloid /3-protein (A/3) fibrils have been found to be taken up predominantly in microglia via class A and class B scavenger receptors and accumulated in the endosomal/lysosomal system (Paresce et al., 1996) . It has also been suggested that cathepsin D may be an A/3-degrading enzyme in human (McDermott and Gibson, 1996) and rat brains (Hamazaki, 1996) . It is therefore possible that cathepsin B, together with cathepsin D, plays a role in degradation of A/3 internalized in the endosomal/lysosomal system of microglia. Further studies to clarify these possible physiological and pathological functions of cathepsin B in microglia are now in progress.
